Ian Bezek

Ian Bezek

InvestorPlace Contributor

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Corsair Gaming Stock Is a Rare Meme Play With Value

By Ian Bezek, InvestorPlace Contributor

Bears continue betting against Corsair. However, they might be in for a rude surprise, as CRSR stock has plenty of positives going for it.

Dutch Bros: The Pros And Cons of This Supercharged Drinks Chain

By Ian Bezek, InvestorPlace Contributor

Dutch Bros is a fantastic growth story with a catchy product that younger consumers love. Valuation is the only concern with BROS stock going forward.

7 Robotics Stocks to Buy to Ride the Automation Wave

By Ian Bezek, InvestorPlace Contributor

The world is going through a massive logistics meltdown. Automation will be a key part of the solution, making these robotics stocks buys.

Coupang Stock Is Getting Interesting After Its Big Decline

By Ian Bezek, InvestorPlace Contributor

CPNG stock has had a rough time since its IPO. Here's why it's time to give the South Korean e-commerce king a fresh look.

DatChat’s Tiny User Base Will Leave Shareholders Disappointed

By Ian Bezek, InvestorPlace Contributor

DATS stock skyrocketed on positive social media chatter. The truth is, however, that hardly anyone actually uses DatChat's applications.

Aggressive Expansion Efforts Won’t End Well for Farmmi Shareholders

By Ian Bezek, InvestorPlace Contributor

Farmmi's agriculture business might hold some promise, but management's poor capital allocation decisions make FAMI stock a sell.

Xenon: Heading Toward Phase III With Strong Momentum

By Ian Bezek, InvestorPlace Contributor

Xenon just delivered strong clinical trial results and leveraged that into a strong fundraising effort. That has XENE stock in a good place going forward.

Hyliion’s Unique Bet on the Future of Trucking

By Ian Bezek, InvestorPlace Contributor

Hyliion has sold off amid the carnage in the EV SPAC space. However, the company's unique product offering could help it rebound.

AMC Stock Could Get Another Rally on Trump SPAC Excitement

By Ian Bezek, InvestorPlace Contributor

A new SPAC backed by former President Trump took the market by storm on Thursday. This will give a big boost to AMC stock as meme trades heat up.

Sundial’s Alcanna Acquisition Could Be a Game-Changer

By Ian Bezek, InvestorPlace Contributor

Investors haven't given SNDL stock its due following the company's impressive turnaround. A recent acquisition could change that.

Load More